Speakers

Jeremy Abbate

VP & Publisher

Scientific American

Ryutaro Adachi

Director, Corporate Venture Investment

Eisai Co. Ltd.

Carolina Aguilar

CEO

INBRAIN Neuroelectronics

Jarrad Aguirre

CEO

Miga Health

Martin Akerman

CTO and Co-Founder

Ensivagenics

Jim Anthony

EVP and Global Head

Parexel Biotech

Drew Armstrong

Executive Editor

Endpoints News

Derk Arts

Founder & CEO

Castor

Ramin Baghirzade

Senior Director, Global Head Commercial, Gene Therapy CDMO Services

Charles River

Anne Bailey

Director, Clinical Tech Innovation

U.S. Department of Veterans Affairs

Kristin Baker Spohn

General Partner

CRV

Dawn Bell

Global Development Head, Strategic Partnerships Team

BIOME by Novartis

Stacy Blain

CEO

Concarlo Therapeutic

Katie Bodner Spielberg

Associate

5AM Ventures

Travis Bond

CEO

Altoida, Inc.

Steve Brozak

President

WBB Securities LLC

Stephen Bruso

Investor

Morning Side Ventures

Tom Burns

Senior VP, Finance and CFO

XOMA

Jay Campbell

Managing Director, Clinical Accelerator & Venture Fund

Cancer Research Institute

Carin Canale-Theakston

CEO & Founder

Evoke Canale

Melissa Carpenter

Chief Scientific Officer, Regenerative Medicine

ElevateBio

James Cavuoto

Editor & Publisher

Neurotech Reports

Hemmie Chang

Partner, Co-Chair, Life Sciences Group; Chair, Licensing & Strategic Alliances Practice

Foley Hoag

Akshay Chellappa

Director, Corporate Development

Gilead

Adrien Châtillon

CEO & Founder

Actipulse Neuroscience

Erik Clausen

Managing Partner

CG Life

Grace Colon

Former CEO

InCarda Therapeutics

Jeremy Curnock Cook

Managing Partner

Bioscience Managers

Allison DeAngelis

Biotech Startups & Venture Capital Reporter

STAT News

Neel Desai

Senior Director, Business Development & Licensing

Biogen

Stuart Dignam

CEO

MTP Connect

Daniel Dornbusch

CEO

Excision BioTherapeutics

Imran Eba

Partner

Action Potential Venture Capital

Stacy Feld

Regional Head, West North America, Australia & New Zealand

Johnson & Johnson Innovation

Simone Fishburn

VP and Editor-in-Chief

BioCentury

Aaron Gani

Founder & CEO

BehaVR

Jennifer Garrison

Co-Founder & Director, Global Consortium for Reproductive Longevity & Equality and Assistant Professor

Buck Institute

Chris Ghadban

Chief of Staff

Alix Ventures

Michael Goldberg

CEO

Surge Therapeutics

Walter Greenleaf

Distinguished Visiting Scholar

Stanford University’s MediaX Program

Kimberly Ha

CEO and Founder

KKH Advisors

Alex Harding

Head of Business Development

CRISPR Therapeutics

Charlie Hartwell

Managing Director

Bridge Builders Collaborative

Paul Hastings

President and CEO

Nkarta Therapeutics

Jim Healy

Managing Partner

Sofinnova

Derek Hicks

Chief Business Officer

Intellia Therapeutics

William Ho

Founder, President and CEO

IN8bio

Beth Hoffman

Founder, President and CEO

Origami Therapeutics

Chihiro Hosoya

Head of Venture Management and Business Development

Astellas Rx+ Business Accelerator

Kevin Huh

CEO

Korea Innovative Medicines Consortium

Tim Hunt

CEO

Alliance for Regenerative Medicine

Mandy Jackson

Managing Editor, US Commercial News

Scrip/The Pink Sheet

Abigail Jenkins

President & CEO

Gamida Cell

Darren Ji

Co-Founder, CEO

Elpiscience

Hyun-Bae Jie

CEO and Chief Technology Officer

Levatio Therapeutics

Ben Johnson

Head of Early Stage

Silicon Valley Bank

Allison Johnston

Vice President, Life Science & Healthcare

Silicon Valley Bank

Matt Kapusta

CEO

uniQure

Elizabeth Kelly

Principal

Pappas Capital

Edward Kliphuis

Partner

Sofinnova Partners

Shigeru Kobayashi

Chairman, President & CEO

Chiome Bioscience Inc.

Ekaterine Kortkhonjia

Senior Director, Early Innovation Partnering

Johnson & Johnson Innovation

Ekaterine Kortkhonjia

Senior Director, Early Innovation Partnering

Johnson & Johnson Innovation

Suma Krishnan

Founder and COO

Krystal Biotech

Vivian Lee

Managing Director

Aqua Partners LLC

Amy Leiser

Associate

Covington

Chandra Leo

Partner

HBM Partners

Ron Leuty

Senior Reporter

San Francisco Business Times

Jeremy Levin

Chairman and CEO

Ovid Therapeutics

Zili Li

Vice President, Head of Asia Pacific Division

Janssen Research & Development

Helen Liang

Founder & Managing Partner

FoundersX Ventures

Han Lim

CBO

DeepCure

Angus Liu

Senior Staff Writer

Fierce Pharma

Yuwen Liu

Founding Partner

Bohe Angel Fund

Philippe Lopes-Fernandes

Executive VP and CBO

Ipsen

Michael Ludwig

Partner

MTS Health Partners

Michael Luther

Global Head Search & Evaluation, Business Development

Astellas Pharma

Crystal Mackall

Ernest and Amelia Gallo Family Professor of Pediatrics and Medicine

Stanford University

Eddie Martucci

Founder and CEO

Akili Interactive Labs

Owen McCarthy

President

MedRhythms

Martina Molsbergen

CEO

C14 Consulting Group LLC

Dave Moore

Senior Vice President, Corporate Development

Novo Nordisk

Aziz Mottiwala

CCO

Tarsus Pharmaceuticals

Lorenz Muller

Chief Commercial Officer

Milestone Pharmaceuticals

Ann Murray

Global Senior Director, Business Development

Charles River Labs

Jeff Myers

President and CEO

Medicaid Health Plans of America

Matthias Müllenbeck

Director, Licensing & Business Development

EMD Serono

Marian Nakada

VP, Venture Investments

Johnson & Johnson Innovation, JJDC

Daniel Oliver

CEO

Rejuvenate Bio

Tim Opler

Partner & Co-Founder

Torreya

Art Pappas

CEO and Managing Partner

Pappas Capital

Ali Pashazadeh

Founder

Treehill Partners

Neel Patel

Executive Managing Director, Head Commercial Advisory Group - Consulting

Syneos Health Consulting

Victor Pikov

CEO

Medipace

Maria Pineda

Co-Founder and CEO

Envisagenics

Cristiana Principato

Senior Data Scientist

Compass Pathways

Linda Pullan

Business Development Consultant

Pullan Consulting

Sachin Purwar

Managing Director, Commercial Advisory Group

Syneos Health

Deborah Rathjen

CEO

Carina Biotech

Adrian Rawcliffe

CEO

Adaptimmune Therapeutics

Nanea Reeves

CEO and Co-Founder

TRIPP, Inc.

Lisa Ricciardi

CEO

Cognition Therapeutics, Inc.

Beth Rogozinski

CEO

Oncoustics

Brian Rosenzweig

Partner

Covington & Burling LLP

Lex Rovner

CEO

64x Bio

Peter Rubin

Executive Director

No Patient Left Behind

Zaki Salanti

Senior Director, Head of Search & Evaluation

Novo Nordisk A/S

Regina Salvat

Principal

Sofinnova Investments

Jodi Scott

Partner

Hogan Lovells US LLP

Bruce Seeley

Former COO

CTI BioPharma

Jaisim Shah

CEO & President

Scilex

Barbara Alcaraz Silva

Director, Early Stage Life Science West Coast

Silicon Valley Bank

Daniel-Adriano Silva

CEO

Monod Bio

Brad Sitko

Chief Investment Officer

XOMA

Devyn Smith

CEO

Arbor Biotechnologies

Andrew Strong

Partner

Hogan Lovells

David Suendermann-Oeft

CEO

Modality.AI, Inc.

Sze-Wee Tan

Assistant Chief Executive

Innovation & Enterprise Group, Agency for Science & Technology Research (A*STAR)

Lee Taurman

Executive Vice President, Global Head, Syneos One®

Syneos Health

Pascal Touchon

CEO

Atara Biotherapeutics

Alice Valder Curran

Partner

Hogan Lovells

John Vandermosten

Senior Biotechnology Analyst

Zacks Investment Research

Brent Vaughan

CEO

Cognito Therapeutics

Uma Verma

Senior Director, Business Development

Biogen

Kulika Weizman

, Principal

Creative Ventures

James Williams

Head of Biogen Digital Health Ventures

Biogen

Richard Wilson

Senior VP, Primary Focus Lead Genetic Regulation

Astellas Pharma

Gwendolyn Wu

Reporter

BioPharma Dive

Peter Young

Venture Partner

Pappas Capital

Hanadie Yousef

CEO

Juvena Therapeutics

Alice Zheng

Principal

RH Capital